Response to 'Long-term outcomes of imiquimod-treated lentigo maligna'
Clin Exp Dermatol
.
2020 Mar;45(2):274.
doi: 10.1111/ced.14090.
Epub 2019 Sep 19.
Authors
D Veitch
1
,
H Smith
1
,
B Olabi
1
,
M Lam
1
,
A Patel
1
,
S Varma
1
Affiliation
1
Department of Dermatology, NHS Treatment Centre, Nottingham, UK.
PMID:
31502672
DOI:
10.1111/ced.14090
No abstract available
Publication types
Letter
Comment
MeSH terms
Aminoquinolines
Humans
Hutchinson's Melanotic Freckle*
Imiquimod
Skin Neoplasms*
Substances
Aminoquinolines
Imiquimod